Inventor · disambiguated record
Zhi Chen
Also filed as: CHEN ZHI · Chen zhi-kuan
22 granted patents·16 pending applications·116 citations·filing 2003–2024
93Inventor score
Files withHOFFMANN LA ROCHE12NINGBO LUMILAN ADVANCED MAT CO LTD12NINGBO LUMILAN ADVANCED MAT LTD4BAYER HEALTHCARE LLC3BAYER PHARMACEUTICALS CORP3
Top patents by PatentIndex Score
38 records- 0194US7838524B2Substituted pyrazolyl urea derivatives useful in the treatment of cancerBAYER HEALTHCARE LLC·Filed 2005·Granted Nov 23, 2010·50 cites·37 claims
- 0291US8207166B2Substituted pyrazolyl urea derivatives useful in the treatment of cancerLEE WENDY·Filed 2010·Granted Jun 26, 2012·24 cites·6 claims
- 0385US7557129B2Cyanopyridine derivatives useful in the treatment of cancer and other disordersBAYER HEALTHCARE LLC·Filed 2004·Granted Jul 7, 2009·18 cites·18 claims
- 0480US7585888B2Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2008·Granted Sep 8, 2009·4 cites·5 claims
- 0579US7384947B2Fused tricyclic heterocycles useful for treating hyper-proliferative disordersBAYER HEALTHCARE LLC·Filed 2006·Granted Jun 10, 2008·2 cites·5 claims
- 0678US8076488B2Bicyclic urea derivatives useful in the treatment of cancer and other disordersDUMAS JACQUES·Filed 2004·Granted Dec 13, 2011·10 cites·32 claims
- 0770US7144885B2Fused tricyclic heterocycles useful for treating hyper-proliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2003·Granted Dec 5, 2006·4 cites·26 claims
- 0867US9693997B2Antiviral compoundsHOFFMANN LA ROCHE·Filed 2014·Granted Jul 4, 2017·1 cites·19 claims
- 0967US7351735B2Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2003·Granted Apr 1, 2008·3 cites·21 claims
- 1066US2010075971A1Substituted pyridine derivatives useful in the treatment of cancer and other disordersDUMAS JACQUES·Filed 2009·Application pending·0 cites
- 1158US2014010783A1Antiviral compoundsHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1255US11342517B2Dibenzoheterocyclic compound and preparation method and application thereofNINGBO LUMILAN ADVANCED MAT CO LTD·Filed 2019·Granted May 24, 2022·0 cites·8 claims
- 1355US2025011647A1Organic electroluminescent compound and application thereofNINGBO LUMILAN ADVANCED MAT CO LTD·Filed 2024·Application pending·0 cites
- 1454US2025031569A1Organic electroluminescent host material composition, light emitting device and applicationNINGBO LUMILAN ADVANCED MAT CO LTD·Filed 2024·Application pending·0 cites
- 1553US11706982B2Fused polycyclic compound, and preparation method and use thereofNINGBO LUMILAN ADVANCED MAT CO LTD·Filed 2020·Granted Jul 18, 2023·0 cites·12 claims
- 1653US11453685B2Dibenzoheterocyclic compound and preparation method and application thereofNINGBO LUMILAN ADVANCED MAT CO LTD·Filed 2019·Granted Sep 27, 2022·0 cites·10 claims
- 1752US11626562B2Fused polycyclic compound, and preparation method and use thereofNINGBO LUMILAN ADVANCED MAT CO LTD·Filed 2020·Granted Apr 11, 2023·0 cites·11 claims
- 1850US9540345B2Antiviral compoundsHOFFMANN LA ROCHE·Filed 2014·Granted Jan 10, 2017·0 cites·2 claims
- 1950US2023125329A1Compound, organic electroluminescence material, organic electroluminescence element and electronic deviceNINGBO LUMILAN ADVANCED MAT CO LTD·Filed 2022·Application pending·0 cites
- 2050US2014242028A1Antiviral compoundsHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 2150US2023157161A1Organic material composition and applications thereofNINGBO LUMILAN ADVANCED MAT CO LTD·Filed 2022·Application pending·0 cites
- 2246US11393982B29,10-dihydro-acridine derivative, and preparation method and use thereofNINGBO LUMILAN ADVANCED MAT LTD·Filed 2019·Granted Jul 19, 2022·0 cites·8 claims
- 2346US2023111454A1Nitrogen-containing fused heterocyclic compound and applications thereofNINGBO LUMILAN ADVANCED MAT CO LTD·Filed 2022·Application pending·0 cites
- 2445US11158814B29,10-dihydro-acridine derivative, and preparation method and use thereofNINGBO LUMILAN ADVANCED MAT LTD·Filed 2019·Granted Oct 26, 2021·0 cites·10 claims
- 2545US9896433B2Antiviral compoundsHOFFMANN LA ROCHE·Filed 2014·Granted Feb 20, 2018·0 cites·15 claims
- 2645US2023140609A1Organic material composition and applications thereofNINGBO LUMILAN ADVANCED MAT CO LTD·Filed 2022·Application pending·0 cites
- 2745US2023134923A1Organic material composition and applications thereofNINGBO LUMILAN ADVANCED MAT CO LTD·Filed 2022·Application pending·0 cites
- 2844US2023110961A1Nitrogen-containing fused heterocyclic compound and applications thereofNINGBO LUMILAN ADVANCED MAT CO LTD·Filed 2022·Application pending·0 cites
- 2942US9511059B2Antiviral compoundsHOFFMANN LA ROCHE·Filed 2015·Granted Dec 6, 2016·0 cites·1 claims
- 3042US2017081312A1Antiviral compoundsHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 3141US2015307461A1Antiviral compoundsBILOTTA JOSEPH A·Filed 2015·Application pending·0 cites
- 3238US2020006668A1Fused cyclic compound, and preparation method and use thereofNINGBO LUMILAN ADVANCED MAT LTD·Filed 2019·Application pending·0 cites
- 3338US2020006669A1Fused cyclic compound, and preparation method and use thereofNINGBO LUMILAN ADVANCED MAT LTD·Filed 2019·Application pending·0 cites
- 3436US9359337B2Acetamide derivativesHOFFMANN LA ROCHE·Filed 2015·Granted Jun 7, 2016·0 cites·18 claims
- 3535US9388166B26-aminoindole derivatives as TRP channel antagonistsHOFFMANN LA ROCHE·Filed 2015·Granted Jul 12, 2016·0 cites·13 claims
- 3635US9353096B2Substituted phenylcarbamate compoundsHOFFMANN LA ROCHE·Filed 2015·Granted May 31, 2016·0 cites·17 claims
- 3734US9580411B2Substituted sulfonamide compoundsHOFFMANN LA ROCHE·Filed 2015·Granted Feb 28, 2017·0 cites·14 claims
- 3833US2015218141A1Substituted carbamate compoundsHOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Zhi Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →